(Q44762282)

English

Infectious disease: CXCL13 is a potential biomarker for Lyme neuroborreliosis

scientific article published on 12 April 2011

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

6 December 2017

Infectious disease: CXCL13 is a potential biomarker for Lyme neuroborreliosis (English)

1 reference

stated in

Europe PubMed Central

6 December 2017

0 references

0 references

1

Katie Kingwell

1 reference

stated in

Europe PubMed Central

PubMed ID

21487424

retrieved

6 December 2017

language of work or name

English

0 references

publication date

12 April 2011

1 reference

stated in

Europe PubMed Central

6 December 2017

Nature Reviews Neurology

1 reference

stated in

Europe PubMed Central

6 December 2017

7

1 reference

stated in

Europe PubMed Central

6 December 2017

5

1 reference

stated in

Europe PubMed Central

6 December 2017

244

1 reference

stated in

Europe PubMed Central

6 December 2017

https://scigraph.springernature.com/pub.10.1038/nrneurol.2011.50

0 references

cites work

A prospective study on the role of CXCL13 in Lyme neuroborreliosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.50

retrieved

31 March 2020

Identifiers

DOI

10.1038/NRNEUROL.2011.50

1 reference

stated in

Europe PubMed Central

PubMed ID

21487424

retrieved

6 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

PubMed ID

21487424

retrieved

6 December 2017

(Q44762282)

Infectious disease: CXCL13 is a potential biomarker for Lyme neuroborreliosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)